Drug shortage: Ifosfamide Injection (IFOSFAMIDE)
FDA lists 8 presentations as Current. Availability: Unavailable (3), Limited Availability (1), Available (4). Reason: Demand increase for the drug; Requirements related to complying with good manufacturing practices. Companies: SteriMax, Inc., Baxter Healthcare, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc..
- Published by source
- 2026-06-12
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- SteriMax, Inc.
- Products
- Ifosfamide Injection IFOSFAMIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418
- Check wholesalers for inventory
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-06-12
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #849 | new | 2026-10-22 | 42fe8c261d4b…e710c3 | 22091761ea9d…f1592e |
Chain head: #1076 8ad5adc30b9b…88ce20